JP2018529766A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018529766A5 JP2018529766A5 JP2018534488A JP2018534488A JP2018529766A5 JP 2018529766 A5 JP2018529766 A5 JP 2018529766A5 JP 2018534488 A JP2018534488 A JP 2018534488A JP 2018534488 A JP2018534488 A JP 2018534488A JP 2018529766 A5 JP2018529766 A5 JP 2018529766A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- testing
- serum
- patient
- single oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000012360 testing method Methods 0.000 claims description 24
- 210000002966 serum Anatomy 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 19
- 206010056438 Growth hormone deficiency Diseases 0.000 claims description 14
- 239000008185 minitablet Substances 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 claims 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims 2
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562221191P | 2015-09-21 | 2015-09-21 | |
| US62/221,191 | 2015-09-21 | ||
| US201662289221P | 2016-01-30 | 2016-01-30 | |
| US62/289,221 | 2016-01-30 | ||
| PCT/US2016/052800 WO2017053373A1 (en) | 2015-09-21 | 2016-09-21 | Detecting and treating growth hormone deficiency |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020213095A Division JP7104768B2 (ja) | 2015-09-21 | 2020-12-23 | 成長ホルモン欠乏症の検出および治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018529766A JP2018529766A (ja) | 2018-10-11 |
| JP2018529766A5 true JP2018529766A5 (enExample) | 2019-08-15 |
| JP6816149B2 JP6816149B2 (ja) | 2021-01-20 |
Family
ID=58276481
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018534488A Active JP6816149B2 (ja) | 2015-09-21 | 2016-09-21 | 成長ホルモン欠乏症の検出および治療 |
| JP2020213095A Active JP7104768B2 (ja) | 2015-09-21 | 2020-12-23 | 成長ホルモン欠乏症の検出および治療 |
| JP2022110116A Active JP7389862B2 (ja) | 2015-09-21 | 2022-07-08 | 成長ホルモン欠乏症の検出および治療 |
| JP2023195764A Active JP7724831B2 (ja) | 2015-09-21 | 2023-11-17 | 成長ホルモン欠乏症の検出および治療 |
| JP2025130430A Pending JP2025170274A (ja) | 2015-09-21 | 2025-08-05 | 成長ホルモン欠乏症の検出および治療 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020213095A Active JP7104768B2 (ja) | 2015-09-21 | 2020-12-23 | 成長ホルモン欠乏症の検出および治療 |
| JP2022110116A Active JP7389862B2 (ja) | 2015-09-21 | 2022-07-08 | 成長ホルモン欠乏症の検出および治療 |
| JP2023195764A Active JP7724831B2 (ja) | 2015-09-21 | 2023-11-17 | 成長ホルモン欠乏症の検出および治療 |
| JP2025130430A Pending JP2025170274A (ja) | 2015-09-21 | 2025-08-05 | 成長ホルモン欠乏症の検出および治療 |
Country Status (23)
| Country | Link |
|---|---|
| US (5) | US9763919B2 (enExample) |
| EP (3) | EP3352752B1 (enExample) |
| JP (5) | JP6816149B2 (enExample) |
| KR (4) | KR102385669B1 (enExample) |
| CN (2) | CN108348501A (enExample) |
| AU (5) | AU2016328969B2 (enExample) |
| CA (1) | CA2998523C (enExample) |
| CY (1) | CY1125183T1 (enExample) |
| DK (2) | DK3352752T3 (enExample) |
| ES (2) | ES2967259T3 (enExample) |
| FI (1) | FI3939590T3 (enExample) |
| HR (1) | HRP20220317T1 (enExample) |
| HU (2) | HUE057831T2 (enExample) |
| IL (1) | IL258224B (enExample) |
| LT (1) | LT3352752T (enExample) |
| PL (2) | PL3352752T3 (enExample) |
| PT (2) | PT3352752T (enExample) |
| RS (1) | RS62988B1 (enExample) |
| SG (2) | SG10202010598SA (enExample) |
| SI (1) | SI3352752T1 (enExample) |
| SM (1) | SMT202200167T1 (enExample) |
| UA (1) | UA123865C2 (enExample) |
| WO (1) | WO2017053373A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11234969B2 (en) * | 2016-01-30 | 2022-02-01 | Lumos Pharma, Inc. | Detecting and treating growth hormone deficiency |
| WO2017053373A1 (en) * | 2015-09-21 | 2017-03-30 | Ammonett Pharm Llc | Detecting and treating growth hormone deficiency |
| US10288629B1 (en) * | 2017-12-19 | 2019-05-14 | Aeterna Zentaris, Inc. | Method of assessing growth hormone deficiency in humans by a macimorelin containing composition |
| WO2020041321A1 (en) | 2018-08-20 | 2020-02-27 | Berkowitz Barry A | Process for the production of cannabinoids |
| US11644474B2 (en) * | 2020-07-22 | 2023-05-09 | Æterna Zentaris Gmbh | Use of macimorelin in assessing growth hormone deficiency in children |
| US11969416B1 (en) * | 2022-11-03 | 2024-04-30 | Lumos Pharma, Inc. | Compactable oral formulations of ibutamoren |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0650597A4 (en) * | 1992-06-29 | 1996-12-18 | Univ South Florida | DIAGNOSTIC METHOD FOR EVALUATING THE AETIOLOGY OF MINOR GROWTH. |
| US5756507A (en) | 1995-12-14 | 1998-05-26 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| EP1021190B1 (en) | 1997-08-22 | 2006-11-08 | Kaken Pharmaceutical Co., Ltd. | Amid derivatives as growth hormone release promotors |
| DE60140285D1 (de) | 2000-05-31 | 2009-12-10 | Pfizer Prod Inc | Verwendung von Wachstumshormonsekretagoga zur Förderung der Beweglichkeit des Verdauungstrakts |
| CZ305279B6 (cs) | 2000-06-13 | 2015-07-15 | Zentaris Ag | Deriváty tryptofanu zvyšující sekreci růstového hormonu |
| CA2538846A1 (en) * | 2003-09-19 | 2005-03-31 | Pfizer Health Ab | Enhanced method of treatment of growth disorders |
| US7674913B2 (en) | 2003-11-12 | 2010-03-09 | Phenomix Corporation | Heterocyclic boronic acid compounds |
| GB0603295D0 (en) | 2006-02-18 | 2006-03-29 | Ardana Bioscience Ltd | Methods and kits |
| WO2013163455A2 (en) * | 2012-04-25 | 2013-10-31 | The Regents Of The University Of California | A drug screening platform for rett syndrome |
| US11234969B2 (en) * | 2016-01-30 | 2022-02-01 | Lumos Pharma, Inc. | Detecting and treating growth hormone deficiency |
| WO2017053373A1 (en) * | 2015-09-21 | 2017-03-30 | Ammonett Pharm Llc | Detecting and treating growth hormone deficiency |
-
2016
- 2016-09-21 WO PCT/US2016/052800 patent/WO2017053373A1/en not_active Ceased
- 2016-09-21 SG SG10202010598SA patent/SG10202010598SA/en unknown
- 2016-09-21 PL PL16849470T patent/PL3352752T3/pl unknown
- 2016-09-21 EP EP16849470.6A patent/EP3352752B1/en active Active
- 2016-09-21 SI SI201631495T patent/SI3352752T1/sl unknown
- 2016-09-21 ES ES21192867T patent/ES2967259T3/es active Active
- 2016-09-21 HU HUE16849470A patent/HUE057831T2/hu unknown
- 2016-09-21 KR KR1020187010804A patent/KR102385669B1/ko active Active
- 2016-09-21 US US15/271,542 patent/US9763919B2/en active Active
- 2016-09-21 CA CA2998523A patent/CA2998523C/en active Active
- 2016-09-21 UA UAA201803953A patent/UA123865C2/uk unknown
- 2016-09-21 KR KR1020257020814A patent/KR20250102122A/ko active Pending
- 2016-09-21 ES ES16849470T patent/ES2908423T3/es active Active
- 2016-09-21 PT PT168494706T patent/PT3352752T/pt unknown
- 2016-09-21 AU AU2016328969A patent/AU2016328969B2/en active Active
- 2016-09-21 SG SG10201902424TA patent/SG10201902424TA/en unknown
- 2016-09-21 EP EP23207876.6A patent/EP4296679A3/en active Pending
- 2016-09-21 SM SM20220167T patent/SMT202200167T1/it unknown
- 2016-09-21 LT LTEPPCT/US2016/052800T patent/LT3352752T/lt unknown
- 2016-09-21 KR KR1020227011483A patent/KR102560838B1/ko active Active
- 2016-09-21 JP JP2018534488A patent/JP6816149B2/ja active Active
- 2016-09-21 HU HUE21192867A patent/HUE065224T2/hu unknown
- 2016-09-21 PT PT211928676T patent/PT3939590T/pt unknown
- 2016-09-21 PL PL21192867.6T patent/PL3939590T3/pl unknown
- 2016-09-21 DK DK16849470.6T patent/DK3352752T3/da active
- 2016-09-21 DK DK21192867.6T patent/DK3939590T3/da active
- 2016-09-21 RS RS20220218A patent/RS62988B1/sr unknown
- 2016-09-21 CN CN201680064316.4A patent/CN108348501A/zh active Pending
- 2016-09-21 KR KR1020237025351A patent/KR20230116961A/ko not_active Ceased
- 2016-09-21 EP EP21192867.6A patent/EP3939590B1/en active Active
- 2016-09-21 CN CN202310486498.6A patent/CN116459250A/zh active Pending
- 2016-09-21 HR HRP20220317TT patent/HRP20220317T1/hr unknown
- 2016-09-21 FI FIEP21192867.6T patent/FI3939590T3/fi active
-
2017
- 2017-09-18 US US15/706,991 patent/US10105352B2/en active Active
-
2018
- 2018-03-19 IL IL258224A patent/IL258224B/en unknown
- 2018-09-20 US US16/136,967 patent/US10898472B2/en active Active
-
2020
- 2020-09-17 AU AU2020233715A patent/AU2020233715B2/en active Active
- 2020-12-23 JP JP2020213095A patent/JP7104768B2/ja active Active
-
2021
- 2021-10-21 AU AU2021254600A patent/AU2021254600B2/en active Active
-
2022
- 2022-01-24 US US17/582,117 patent/US12539293B2/en active Active
- 2022-03-18 CY CY20221100219T patent/CY1125183T1/el unknown
- 2022-07-08 JP JP2022110116A patent/JP7389862B2/ja active Active
-
2023
- 2023-11-17 JP JP2023195764A patent/JP7724831B2/ja active Active
-
2024
- 2024-03-14 AU AU2024201658A patent/AU2024201658C1/en active Active
-
2025
- 2025-03-21 US US19/086,686 patent/US20250213536A1/en active Pending
- 2025-08-05 JP JP2025130430A patent/JP2025170274A/ja active Pending
- 2025-09-24 AU AU2025237934A patent/AU2025237934A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018529766A5 (enExample) | ||
| Morimoto et al. | A double-blind, placebo-controlled, ascending-dose, randomized study to evaluate the safety, tolerability and effects on cognition of AL-108 after 12 weeks of intranasal administration in subjects with mild cognitive impairment | |
| Noppers et al. | Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: a report of 3 cases | |
| CA2688766C (en) | Compositions and methods for treatment of multiple sclerosis | |
| US20210077382A1 (en) | Compositions, devices, and methods for the treatment of opioid-receptor-mediated conditions | |
| EP2335732A3 (en) | Multiple-variable dose regimen for treating TNF-alpha-related disorders | |
| JP2015520188A5 (enExample) | ||
| JP2010515774A5 (enExample) | ||
| FI3939590T3 (fi) | Kasvuhormonin puutoksen tunnistaminen ja hoitaminen | |
| JP2019533672A5 (enExample) | ||
| FI3359572T3 (fi) | Menetelmä multippeliskleroosin hoitamiseksi | |
| CN105769876B (zh) | 胆汁酸成分及熊胆的医药用途 | |
| Rathbone et al. | Design and development of systemic oral mucosal drug delivery systems | |
| Akhmedzhanova et al. | Diagnosis and treatment of chronic pelvic pain syndrome | |
| JP7121859B2 (ja) | 安息香酸塩または安息香酸誘導体を含む、抗ｎ－メチル－ｄ－アスパラギン酸受容体脳炎を予防または治療するための医薬組成物 | |
| AU2015305430A1 (en) | Method for treating hyperhidrosis | |
| Ahmadi et al. | Guillain–Barre syndrome: a prevalent autoimmune disease during the coronavirus disease-2019 pandemic | |
| CN103520437B (zh) | 一种治疗痛经的中药贴剂及其制备方法和应用 | |
| JP2019001830A (ja) | 医薬 | |
| NZ741142B2 (en) | Detecting and treating growth hormone deficiency | |
| Stoll et al. | Severe acute inflammatory demyelinating polyradiculoneuropathy with persistent weakness associated with tumor-like nerve root enlargement | |
| Urokovich | Combination therapy of the bronchial hyperresponsiveness | |
| Meti | Ramosetron vs Palonosetron in Preventing Postoperative Nausea and Vomiting in Laparoscopic Surgeries-A Clinical Comparision | |
| Sun et al. | Effect of acupuncture combined with spiral nasojejunal intubation on enteral nutrition in critically ill patients | |
| Prenner et al. | A Post-Hoc Analysis Of Asthma Control And Lung Function Following Treatment With Ciclesonide 80 μg HFA-MDI Twice Daily In Subjects With Mild-to-Moderate Persistent Asthma Previously Receiving Low Dose Fluticasone Propionate/Salmeterol |